• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 175

Substance: Saccharomyces cerevisiae strain ECMo01 with enhanced expression of urea amidolyase
Intended Use: Reduction of ethyl carbamate in fermented beverages
Basis: Scientific procedures
Notifier: First Venture Technologies Corp.
Suite 1500, 885 West Georgia Street, Vancouver, British Columbia, V6C 3E8, CANADA
Date of filing: Jul 12, 2005
GRAS Notice (releasable information): 175
Date of closure / FDA's Letter: Jan 6, 2006
FDA has no questions